VIP Polyklonaler Antikörper

VIP Polyklonal Antikörper für IF

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte

Anwendung

IF

Konjugation

CoraLite® Plus 488 Fluorescent Dye

Kat-Nr. : CL488-16233

Synonyme

PHM27, vasoactive intestinal peptide, VIP, VIP peptides

---

Galerie der Validierungsdaten

• 

  IF Staining of mouse colon using CL488-16233

  Immunofluorescent analysis of (4% PFA) fixed mouse colon tissue using CoraLite® Plus 488 VIP antibody (CL488-16233) at dilution of 1:200.

• 

  IF Staining of mouse colon using CL488-16233

  Immunofluorescent analysis of (4% PFA) fixed mouse colon tissue using CoraLite® Plus 488 VIP antibody (CL488-16233) at dilution of 1:200.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in IF: Maus-Kolongewebe

Empfohlene Verdünnung

• Immunfluoreszenz (IF): IF : 1:50-1:500

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Produktinformation

CL488-16233 bindet in IF VIP und zeigt Reaktivität mit human, Maus, Ratten

• Getestete Reaktivität: human, Maus, Ratte
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: VIP fusion protein Ag8933
• Vollständiger Name: vasoactive intestinal peptide
• Berechnetes Molekulargewicht: 169 aa, 19 kDa
• GenBank-Zugangsnummer: BC009794
• Gene symbol: VIP
• Gene ID (NCBI): 7432
• Konjugation: CoraLite® Plus 488 Fluorescent Dye
• Excitation/Emission maxima wavelengths: 493 nm / 522 nm
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: BS mit 50% Glyzerin, 0,05% Proclin300, 0,5% BSA, pH 7,3.
• Lagerungsbedingungen: Bei -20°C lagern. Vor Licht schützen. Nach dem Versand ein Jahr stabil. Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Vasoactive intestinal peptide (VIP), a short peptide containing 28 amino acids belonging to the secretin-glucagon family, is initially isolated from the gastrointestinal tract as a potent vasodilator peptide. VIP was initially identified in normal nervous tissue and neurons and was subsequently recognized as a neurotransmitter widely distributed in various tissues. The wide distribution of VIP determines its involvement in a range of biological activities, such as gut motility, hormonal regulation, circadian rhythms, immune responses, and carcinogenesis. The general physiologic effects of VIP include vasodilation, anti-inflammatory actions, cell proliferation, hormonal secretion, regulation of gastric motility, and smooth muscle relaxation; therefore, VIP has emerged as a promising drug candidate for the treatment of several diseases.